![Ira Duarte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ira Duarte
Finanzdirektor/CFO bei
HERON THERAPEUTICS, INC.
Vermögen: 557 555 $ am 30.06.2026
Profil
Ira Duarte is currently an Independent Director at Terrascend Corp.
since 2022 and EVP, Chief Financial & Accounting Officer at Heron Therapeutics, Inc. starting in 2024.
Former positions include Chief Financial Officer & VP-Controller at Veloxis Pharmaceuticals A from 2018 to 2023, Controller at BioDelivery Sciences International, Inc. from 2014 to 2016, Director-Accounting & Financial Planning at Chiesi USA, Inc. from 2009 to 2013, and Senior Manager at Ernst & Young A. Education includes undergraduate studies at Florida Atlantic University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TERRASCEND CORP. 0,21 % | 30.06.2026 | 657 930 ( 0,21 % ) | 446 077 $ | 30.06.2026 |
HERON THERAPEUTICS INC 0,14 % | 16.06.2026 | 261 073 ( 0,14 % ) | 111 478 $ | 30.06.2026 |
Aktive Positionen von Ira Duarte
| Unternehmen | Position | Beginn |
|---|---|---|
| TERRASCEND CORP. | Direktor/Vorstandsmitglied | 02.12.2022 |
| HERON THERAPEUTICS, INC. | Finanzdirektor/CFO | 16.06.2023 |
Ehemalige bekannte Positionen von Ira Duarte
| Unternehmen | Position | Ende |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Finanzdirektor/CFO | 01.01.2023 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Comptroller/Controller/Auditor | 01.01.2016 |
| CORNERSTONE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.10.2013 |
Ernst & Young A/S
 Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Ausbildung von Ira Duarte
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Florida Atlantic University
 Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Terrascend Corp.
 Terrascend Corp. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
